Parkinson's disease (PD) is a complex, slowly progressive, neurodegenerative, neurological condition characterised by a wide range of motor problems such as movement disorders, issues with gait and balance, and difficulty with swallowing and speech. In addition, sufferers also experience non-motor symptoms such as disorder of sleep, postural hypotension, mood alterations, lethargy, and cognitive dysfunction. As PD progresses to an advanced stage, people experience periods of debilitating physical and neurological problems and their caregivers face increasing complexity of care. Many people with PD require the support of a caregiver to attend to activities of daily living. This paper will review the literature on the effects of Parkinson's disease on both the patient and caregiver. Findings highlight the progressive nature of the disease affecting both functional and affective domains, and the need for caregiver support to enable the delivery of quality of care to this group throughout the disease trajectory.
INTRODUCTION
Parkinson's disease (PD) is a complex, slowly progressive, neurodegenerative neurological condition 1 . It is common and affects an estimated four million people worldwide, and is expected to double by the year 2030 2 . This highlights the growing global burden of PD. Eventually many people with PD need the support of a caregiver 3 . Informal caregivers include kin and non-kin individuals who provide both functional (taskoriented) and affective (emotional) unpaid assistance to a person with whom a long-term or life-long commitment usually exists 4 . As such, family members are the major source of informal care for people with PD [5] [6] [7] [8] .
James Parkinson, an English physician and geologist described PD as the "shaking palsy" (paralysis agitans) in 1817 9 . A hundred years later, it was discovered that PD was due to a loss of dopamineproducing cells in the substantia nigra 10 . The progressive loss of dopaminergic neurons leads to an array of clinical features that can be a challenge to manage. The cardinal features are tremor, rigidity, akinesia or bradykinesia, rigidity and in the later stages of the disease, postural instability 11 . By the time the motor symptoms appear, it is estimated that the disease onset may have started around four to five years previously. When patients become symptomatic, approximately 60% of nigral dopaminergic neuron cells and up to 80% of striatal dopamine are lost 12 . 
METHOD

IMPACT OF PARKINsON's DIsEAsE
Studies have suggested that symptoms affecting the ability to function and cope psychosocially are the most challenging facet of PD 13 . There have been many reports of the negative impacts of PD on the quality of life of patients and their caregivers [14] [15] [16] . For example, depression is a common co-morbid condition in people with PD which contributes to caregiver burden, affecting the caregiver's quality of life 16 . Correlations between decreased serotonin and noradrenaline cerebrospinal fluid metabolites and behavioural indices of depression have been established for endogenously depressed people. Both these neurotransmitters are depleted in people with PD 17 .
Neuropsychiatric Disturbances
Depression in PD can be difficult to diagnose because depressive symptoms may overlap with PD symptoms 18 . In addition, depression can compromise the ability to manage activities of daily living 19, 20 . An early study conducted by Schulz, Tompkins, Wood, and Decker 21 did not identify a relationship between psychological well-being and caregiver depression.
Neuropsychiatric disturbances sometimes occur in the later stages of PD 22 and contribute considerably to a reduced quality of life 23 . An analysis of 537 people with PD recruited from an international multicentre clinical trial of the medication Rivastigmine, a cholinergic agent for the treatment of dementia due to PD, revealed that 89% presented with at least one neuropsychiatric symptom, while 77% had two or more neuropsychiatric symptoms 24 . The most common symptoms were depression (58%), apathy (54%), anxiety (49%), and hallucinations (44%). A survey of 99 people with PD revealed that 36% had depression, 33% had anxiety, 40% had fatigue, 47% had sleep disturbance, and 63% reported sensory symptoms 25 .
The number of symptoms is related to the level of disability in people with PD 26 . In a study of 114 people with PD in the USA, Weintraub et al 26 found that severity of depression, worsening cognition, and increasing severity of PD were associated with greater disability. Other contributing factors include psychosis, depressive disorders, cognitive impairment, apathy, sleepiness, motor impairment, and dyskinesia. Although apathy is not regarded as depression 27 , it is frequently observed to occur together with depression 22 . Depression is characterised by anhedonia, "hopelessness or low mood" while apathy is associated more with lack of motivation and initiative 28 . Mental disturbances, such as mood disorders were reported as the main determinants of health-related quality of life (HRQoL) in a study of 115 Brazilians with PD 29 .
Motor Symptoms
The myriad of symptoms that can accompany PD are often inter-related and affect the caregiver experience. Approximately 40% of PD patients experience motor fluctuations and a similar percentage experience dyskinesias after five years of levodopa therapy 30 . A study of 260 PD outpatients in Finland found an inverse relationship between the duration of motor fluctuations and quality of life 31 .
Physical disability in PD is often related to falls.
In the early stages of PD, falls are uncommon but as the disease progresses, falls become one of the most serious complications of PD 32 . A survey (n=1131) with 79.8% response rate of people with Parkinsonian disorders found that age, disease duration, diagnosis of Parkinsonism, and dementia were significant risk factors for falls 33 . Although this study was retrospective, which may result in recall bias, the high response rate suggested that people with PD and their caregivers place considerable importance on the problem of falls.
Falls are common in advanced PD due to age, disease duration, and postural instability. Frenklach et al 34 established that postural instability in dynamic conditions became worse with increasing disease severity and was linked to an increased risk of falls. A study by Kamata et al 35 on 21 people with PD, sex-matched with a control group of healthy elderly volunteers in Japan, demonstrated that people with PD overestimated stability limits, resulting in loss of balance and falls. A survey of 600 falls in people with PD in the United Kingdom found that most falls occurred at home where the single largest cause was tripping followed by turning, reaching, and rising from a chair or bed 36 . The survey revealed that one in three falls was from a standing posture. Mak and Pang 37 found that fear of falling was associated with recurrent falls. They reported that fear of falling may contribute to postural instability and increase the risk of future falls, which may cause self-induced mobility restriction and functional decline.
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Freezing of gait and motor blocks are disabling symptoms of PD 38 . Freezing commonly affects the legs while walking and happens suddenly with a transient inability to move. When freezing occurs, there may be hesitation when beginning to walk, sudden inability to move the feet during turning or walking through a narrow passage, crossing busy streets, or approaching a destination 11 . Freezing impedes daily activities and increases the risk of falling which contributes to reduced quality of life 39 . Data from a mailed questionnaire survey of 6620 members of the German Parkinson Association, with a response rate of 63%, revealed that 47% of respondents reported experiencing freezing regularly. Logistic regression analysis showed that freezing was significantly associated with increased disease duration and severity 40 . A limitation of this study was that it did not distinguish between those who had on-and-off-freezing, freezing of gait, or other movement disorders.
Autonomic Dysfunction
Autonomic dysfunction such as orthostatic hypotension, bladder and bowel dysfunction, sialorrhoea (excessive salivation), constipation, sexual dysfunction, and disturbances in thermal regulation are common features in the later stages of PD 41, 42 . A review by Dubow 42 mentioned that autonomic dysfunction can occur at any stage of PD and that its symptoms were associated with a high disability rating and poor quality of life. A study by Goldstein 43 ascertained that orthostatic hypotension can occur early in the disease. People with PD who suffer from symptomatic orthostatic hypotension have postural events that lead to an increased risk of falls. Symptomatic orthostatic hypotension occurred in 20% of people with PD 44 , which has been related to duration and severity of the disease and the use of higher daily doses of levodopa and bromocriptine, medications used in the clinical treatment of PD 45 found that autonomic dysfunction causing slow colonic motility was the most likely cause of constipation. These researchers found that medications were generally not the initiating event in constipation but rather that they potentiated a pre-existing delay in colonic transit, particularly for anticholinergic medications, which are known to have distinct effects on intestinal motility. However, constipation in PD was identified before any specific treatment was established 9, 50 . Other contributing factors could be reduced exercise and physical activity, as well as reduced intake of fibre and water due to eating difficulties associated with PD. In a study comparing treated and untreated people with PD whose levels of activity were not significantly different, 35% of the treated people with PD reported constipation compared to only 5% of those whose PD was untreated. The authors concluded that decreased activity by itself did not account for differences in constipation rates 51 . Thus, the cause of constipation in PD is multifactorial, complicating its management.
Urinary dysfunction can also be a problem for some people with PD. In a study of urodynamic assessments in people with PD with neurogenic and non-neurogenic voiding dysfunction, Defreitas et al 52 reported an increased rate of urinary incontinence in people with PD compared to people with non-neurogenic detrusor overactivity. Neurogenic dysfunction causes symptoms of urinary dysfunction such as frequency of micturition, urgency, urinary incontinence, and incomplete emptying of the bladder 53 . The incidence of obstructive urinary symptoms increases with PD severity 54 resulting in greater demand and burden for caregivers.
Effect of Behavioural Disturbances on Caregivers and Patients
Behavioural disturbances in PD can be a source of major difficulties for both patients and caregivers. Impulse control disorders, obsessive-compulsive disorders, and addiction-like behaviour were seen in all stages of the disease [55] [56] [57] . Additionally, Glosser et al 57 found that some people with PD had lessened extroversion and exploratory thoughts, and reduced curiosity, organisation, goal direction, and discipline. Another study found that people with PD developed a heightened interest or drive for gambling, shopping, eating, or sexual activity 58 . Sexual dysfunction is common in PD but has not yet been well researched. Data on sexual Proceedings of Singapore Healthcare  Volume 22  Number 3  2013 dysfunction is incomplete and often contradictory indicating the need for more rigorous studies 59 . A survey of 32 women and 43 men with PD revealed that some people with PD suffered from sexual dysfunction 60 . Cannas et al 61 reported a study of nine people with PD who had developed aberrant sexual behaviour whilst undergoing dopaminergic medication treatment.
Some studies have revealed that these new behaviours were associated with the use of high doses of dopamine agonist medications 58, 62 . Hedonistic homeostatic deregulation, a rare but pervasive behavioural syndrome resulting from compulsive levodopa misuse, was described by researchers in 2000 63 . The condition was usually associated with severe dyskinesias, hypomania, or manic psychosis, and two of the 15 people with this behavioural syndrome developed pathological gambling. Pathological gambling and hypersexuality related to PD medications often had devastating consequences for the whole family 62 . However, these pathological behaviours could potentially be reversed when the dopamine agonist medication is discontinued 62, 64 .
Dysathria, Dysphagia and Sialorrhoea
People with PD often have dysarthria, hypophonia, dysphagia, and sialorrhoea from bulbar dysfunction, which have been attributed to orofacial-laryngeal bradykinesia and rigidity 11 . Speech disorders in people with PD are characterised by monotonous, soft and breathy speech with frequent wordfinding difficulties 65 . These changes impair the ability to communicate and enhance stress in social interactions 66 . Additionally, spontaneous facial expressions may be reduced 66, 67 .
Dysphagia is usually caused by an inability to initiate the swallowing reflex or by a prolongation of laryngeal or oesophageal movement 11 . A survey of people with PD 51 found that dysphagia involved oropharyngeal and upper oesophageal sphincter muscles and was frequently associated with choking and sialorrhoea. Another study looking at 21 people with PD and 13 controls who were evaluated using a modified barium swallow before and after oral levodopa found that 15 people with PD and only one control had abnormal swallowing 68 . The authors reported that people with PD also had silent aspiration from abnormal swallowing without dysphagia. This finding was consistent with a video fluoroscopy study of six people with PD, where aspiration was suggested to result from rigidity or bradykinesia of the epiglottic, laryngeal, and pharyngeal musculature 65 . Most were "silent aspirators" with decreased cough reflexes and lack of awareness of aspiration.
A semi-structured interview of 37 people with PD and their families exploring their experiences of living with impaired swallowing revealed that physical changes affecting swallowing had psychosocial effects on both people with PD and their families 69 . A few family members reported that difficulty with swallowing were significant factors that added to their perceived caring burden.
Sialorrhoea, an excessive accumulation of saliva and drooling in PD, may be caused by infrequent swallowing, dysphagia, and abnormal posture. In a review of studies, researchers found that this symptom occurs in up to 80% of people with PD 70 . A study involving 83 people with idiopathic PD revealed that sialorrhoea was not due to a salivary defect but was related to difficulties in swallowing 71 . Chou et al 70 cited anecdotal reports that people with PD were unwilling to socialise because of this embarrassing symptom. Sialorrhoea may be treated with oral anticholinergic and antihistamine mediations, botulinum toxin A injections, or surgical treatment; however, data to support their efficacy is limited, and all treatments may have adverse side effects 42 . Although sialorrhoea is a common problem in PD, very few studies have addressed this problem and some caregivers may find its management challenging.
Advanced PD
At the advanced stage of PD, people with PD experience periods of debilitating physical and neurological problems 72, 73 and their caregivers face increasing complexity of care. People with PD have a two-to five-fold increased risk of mortality 74, 75 with pneumonia and cachexia the most frequent causes of death 74 . Goy, Carter, and Ganzini 76 interviewed 47 PD caregivers who reported that 26% of their care recipients in the terminal trajectory were fed by tube and 30% required breathing support.
DIsCUssION
PD causes movement disorders, problems with gait and balance that increase the risk of falls and injuries, and problems with swallowing and speech. Motor complications can reduce the HRQoL of people with PD. People with PD also experience a wide range of non-motor symptoms including disorder of sleep, postural hypotension, alterations in mood, lethargy, and cognitive dysfunction. While medications and surgical treatments can improve these symptoms in the short-term, there is no known cure for the disease. In the early stages of PD, medication can sometimes enable patients to remain functionally independent. As the disease progresses, medication becomes less effective and independence decreases to the stage where fulltime caregiving is required to deliver increasingly complex care.
CONCLUsION
Parkinson's disease interferes with physical and social functioning and affects the quality of life of the people with PD and their caregivers. Healthcare professionals increased recognition of the problems affecting people with PD can improve the quality of care for this group and appropriate support for their caregivers. PD is a progressive disease where disease management is required to encompass the present state, plan for future changes, as well as provide palliative care.
